高级检索
当前位置: 首页 > 详情页

TEAD4对结直肠癌细胞增殖影响及机制探讨

Role of TEAD4 in colorectal cancer cells proliferation and its mechanism analysis

| 认领 | 导出 |

文献详情

资源类型:

收录情况: ◇ 统计源期刊 ◇ 北大核心

机构: [1]First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China
出处:
ISSN:

关键词: Cell proliferation Colorectal cancer Knockdown P27 TEAD4

摘要:
OBJECTIVE Colorectal cancer is one of the major cause of tumor death all over the world. TEAD4 is the key factor in the YAP/TAZ signal path. This study aimed to investigate the effect and mechanism of knockdown TEAD4 for colorectal cancer cells proliferation.METHODS Transient transfection and lentivirus system are used to achieve transient or stable knockdown TEAD4 cells of Caco2 and HT-29. Western Blot is employed to detect transfection efficiency and related protein expression. SRB method and EDU Imaging Kits are used to determine cell viability and DNA synthesis.RESULTS Western blot showed knockdown of transcriptional factor TEAD4 could increase the expression of cell cycle protein p27 in Caco2 (F=45.78,P<0.001) and HT-29 (F=40.71,P<0.001) cells. SRB assays showed after using TEAD4sh#2 & TEADsh#3 to stabilize silencing TEAD4 expression in Caco2 and HT-29 cells, compared with the control group, the cell viability of TEAD4 knockdown cells Caco2(F=142.9,P<0.001) and HT-29(F=141.0,P<0.001) were significantly decreased at 2 days. The inhibition effect was more obvious, and the growth rate of Caco2(F=394.5,P<0.001) and HT-29(F=305.1,P<0.001) were significantly slower in 3 days. EdU assay demonstrated after knockdown TEAD4si#2 and TEAD4si#3 in Caco2 and HT-29 cells, DNA synthesis were (43.20±2.18)%, (27.19±2.34)%, (30.14±1.02)% and (28.23±3.11)%, (11.89±1.20)%, (17.91±2.23)%. Compared with control group, DNA synthesis was significantly inhibited in Caco2(Psi#2=0.001,Psi#3P<0.001) and HT-29 cells (Psi#2=0.001,Psi#3=0.011).CONCLUSION This study demonstrated that TEAD4 plays an important role in colorectal cancer Caco2 and HT-29 cells proliferation, partially through up-regulating p27, suggesting that TEAD4 is a potential target and biomarker for the development of novel therapeutics for colorectal cancer. © 2017, Editorial Board of Chinese Journal of Cancer Prevention and Treatment. All right reserved.

语种:
第一作者:
第一作者机构: [1]First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China
通讯作者:
推荐引用方式(GB/T 7714):

资源点击量:70796 今日访问量:0 总访问量:2273 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司